Statistics at a Glance
At a Glance
Estimated New Cases in 2023 3,970
% of All New Cancer Cases 0.2%
Estimated Deaths in 2023 2,140
% of All Cancer Deaths 0.4%
|Year||Rate of New Cases — SEER 8||Rate of New Cases — SEER 12||Death Rate — U.S.||5-Year Relative Survival — SEER 8|
|Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend|
New cases come from SEER 12. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of bone and joint cancer was 1.0 per 100,000 men and women per year. The death rate was 0.5 per 100,000 men and women per year. These rates are age-adjusted and based on 2016–2020 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 0.1 percent of men and women will be diagnosed with bone and joint cancer at some point during their lifetime, based on 2017–2019 data.
Prevalence of This Cancer: In 2020, there were an estimated 60,676 people living with bone and joint cancer in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Bone and Joint Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 22 (Excluding IL/MA) 2013–2019. Gray figures represent those who have died from bone and joint cancer. Green figures represent those who have survived 5 years or more.
New Cases and Deaths
How Common Is This Cancer?
Compared to other cancers, bone and joint cancer is rare.
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||297,790||43,170|
|3.||Lung and Bronchus Cancer||238,340||127,070|
|5.||Melanoma of the Skin||97,610||7,990|
|7.||Kidney and Renal Pelvis Cancer||81,800||14,890|
|29.||Bone and Joint Cancer||3,970||2,140|
Bone and joint cancer represents 0.2% of all new cancer cases in the U.S.
In 2023, it is estimated that there will be 3,970 new cases of bone and joint cancer and an estimated 2,140 people will die of this disease.
Who Gets This Cancer?
Osteosarcoma is most common in teenagers. Ewing Sarcoma is most common in teenagers and young adults. The rate of new cases of bone and joint cancer was 1.0 per 100,000 men and women per year based on 2016–2020 cases, age-adjusted.
|Non-Hispanic American Indian/Alaska Native||Not Shown, <16 cases|
|Non-Hispanic Asian/Pacific Islander||0.9|
|Non-Hispanic American Indian/Alaska Native||1.3|
|Non-Hispanic Asian/Pacific Islander||0.7|
SEER 22 2016–2020, Age-Adjusted
|Age Range||Percent of New Cases|
Bone and joint cancer is most frequently diagnosed among people aged <20.
SEER 22 2016–2020, All Races, Both Sexes
Who Dies From This Cancer?
The death rate was 0.5 per 100,000 men and women per year based on 2016–2020 deaths, age-adjusted.
|Non-Hispanic American Indian/Alaska Native||0.6|
|Non-Hispanic Asian/Pacific Islander||0.4|
|Non-Hispanic American Indian/Alaska Native||0.3|
|Non-Hispanic Asian/Pacific Islander||0.3|
U.S. 2016–2020, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of bone and joint cancer deaths is highest among people aged 65–74.
U.S. 2016–2020, All Races, Both Sexes
Trends in Rates
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new bone and joint cancer cases have been rising on average 0.3% each year over 2010–2019. Age-adjusted death rates have been rising on average 1.7% each year over 2011–2020. 5-year relative survival trends are shown below.
Interactive Statistics with SEER*Explorer
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.Explore Additional Bone and Joint Cancer Statistics
More About This Cancer
Cancer and the Bone and Joint
Primary bone cancer is cancer that forms in cells of the bone. Some types of primary bone cancer are osteosarcoma, Ewing sarcoma, malignant fibrous histiocytoma, and chondrosarcoma. Secondary bone cancer is cancer that spreads to the bone from another part of the body (such as the prostate, breast, or lung). Primary bone cancer is far less common than cancer that spreads to the bones.
Bone cancer is a malignant tumor of the bone that destroys normal bone tissue. Not all bone tumors are malignant. In fact, benign (noncancerous) bone tumors are more common than malignant ones.
Common types of primary bone and joint cancer include the following:
- The Ewing Sarcoma Family of Tumors (ESFTs)
Here are some resources for learning more about bone and joint cancer.
- About risk factors for osteosarcoma
- About symptoms and diagnosis of osteosarcoma
- About symptoms and diagnosis of Ewing Sarcoma
- About treatment options for osteosarcoma
- About treatment options for Ewing Sarcoma
- About clinical trials
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Bone and Joint Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/bones.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2023 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.